HEALTHCARE (XLV)
144.30
+0.32 (0.22%)
NYSE · Last Trade: Oct 31st, 3:24 AM EDT
Detailed Quote
| Previous Close | 143.98 | 
|---|---|
| Open | 143.96 | 
| Day's Range | 143.77 - 145.44 | 
| 52 Week Range | 127.35 - 150.95 | 
| Volume | 10,756,081 | 
| Market Cap | 356.44M | 
| Dividend & Yield | 2.500 (1.73%) | 
| 1 Month Average Volume | 11,199,595 | 
Chart
News & Press Releases
As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush.
Via Benzinga · October 30, 2025
As markets enter their strongest stretch, ETFs tied to AI, banking, and healthcare could shine. Here's where investors are finding fresh momentum.
Via Benzinga · October 30, 2025
CEO Dave Ricks told CNBC that the first study the company plans to read out for Retatrutide will be on knee pain.
Via Stocktwits · October 30, 2025
Trump Steps Up Pressure On Trading Partners Over Drug Costs, Plans Section 301 Review: Reportstocktwits.com
Via Stocktwits · October 22, 2025
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome Powell th
Via Benzinga · October 30, 2025
A powerful surge in AI-related stocks — led by a 9% advance in NVIDIA Corp. (NASDAQ:NVDA) over the past two sessions — propelled the S&P 500 above the 6,900 mark and lifted the Nasdaq 100 to 26,100 points, both breaking new records, as investors brace for the Federal Reserve's
Via Benzinga · October 29, 2025
Tech stocks hit new highs as the Nasdaq 100 rallies 0.7% midday. Investors eye a Fed rate cut, Trump-Xi meeting, and major tech earnings.
Via Benzinga · October 28, 2025
Co-Diagnostics (CODX) stock falls over 50% as they announced a $7 million offering and Saudi joint venture, causing concerns about dilution.
Via Benzinga · October 28, 2025
Short seller Hunterbrook stated that at least 13 G7 users have died since the device launched in 2023. 
Via Stocktwits · October 28, 2025
While the consensus EPS estimate suggests a decline from a year ago, revenue is expected to rise by more than 12% year over year.
Via Stocktwits · October 28, 2025
Wall Street extended its record-setting streak on Monday, with major large-cap indices logging a third consecutive session of strong gains after a breakthrough in trade negotiations between Washington and Beijing.
Via Benzinga · October 27, 2025
Wall Street surged to fresh all-time highs Friday as a softer-than-expected inflation reading strengthened market conviction that the Federal Reserve will cut interest rates by 25 basis points at its Oct. 30 policy meeting. 
Via Benzinga · October 24, 2025
Energy markets dominated headlines Thursday as a fresh wave of U.S. sanctions targeting Russia's oil giants sparked a sharp rebound in crude prices and lifted energy shares.
Via Benzinga · October 23, 2025
Risk sentiment deteriorated sharply on Wednesday as a wave of disappointing earnings guidance and escalating U.S.-China trade tensions rattled investor confidence.
Via Benzinga · October 22, 2025
Gold prices suffered a sharp correction on Tuesday as investors locked in profits following this year's explosive rally, while optimism across earnings kept industrial stocks powering higher and pushed the Dow Jones to fresh record highs.
Via Benzinga · October 21, 2025